|
Market Closed -
Nasdaq
21:00:00 16/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 64.72 USD | -9.01% |
|
-8.76% | +9.60% |
| 10-07 | Tempus Enters Multiyear Collaboration With Moderna, Merck Aimed at Commercializing Cancer Drug | DJ |
| 10-07 | Tempus Expands Moderna, Merck Collaboration for Individualized Cancer Therapy | MT |
Company Valuation: Tempus AI, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| Market Cap 1 | 5,315 | 10,505 | 11,678 | - | - |
| Change | - | 97.64% | 11.16% | - | - |
| Enterprise Value (EV) 1 | 5,302 | 10,990 | 12,322 | 12,207 | 11,976 |
| Change | - | 107.29% | 12.12% | -0.93% | -1.89% |
| P/E | -5.42x | -41.9x | -46.4x | -47.5x | -88.8x |
| PBR | 94.1x | 20.8x | 24.8x | 21.3x | 16x |
| PEG | - | 0.5x | 41.94x | 20.78x | 1.9x |
| Capitalization / Revenue | 7.67x | 8.26x | 7.32x | 5.93x | 4.93x |
| EV / Revenue | 7.65x | 8.64x | 7.72x | 6.2x | 5.06x |
| EV / EBITDA | -50.6x | -1,488x | 189x | 79.9x | 43.5x |
| EV / EBIT | -37.3x | -233x | -1,422x | 242x | 66.5x |
| EV / FCF | -25.1x | -46x | 151x | 244x | 96.6x |
| FCF Yield | -3.98% | -2.18% | 0.66% | 0.41% | 1.04% |
| Dividend per Share 2 | - | - | - | - | - |
| Rate of return | - | - | - | - | - |
| EPS 2 | -6.23 | -1.41 | -1.394 | -1.363 | -0.7287 |
| Distribution rate | - | - | - | - | - |
| Net sales 1 | 693.4 | 1,272 | 1,595 | 1,969 | 2,369 |
| EBITDA 1 | -104.7 | -7.385 | 65.32 | 152.8 | 275.6 |
| EBIT 1 | -142 | -47.19 | -8.663 | 50.48 | 180 |
| Net income 1 | -746.3 | -245 | -246.1 | -247.5 | -135 |
| Net Debt 1 | -13.71 | 484.5 | 643.8 | 529.5 | 298.3 |
| Reference price 2 | 33.76 | 59.05 | 64.72 | 64.72 | 64.72 |
| Nbr of stocks (in thousands) | 157,446 | 177,907 | 180,435 | - | - |
| Announcement Date | 24/02/25 | 24/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -46.41x | 7.72x | 188.62x | -.--% | 11.68B | |
| 18.77x | 6.69x | 13.41x | 1.58% | 65B | |
| 35.3x | 6.27x | 18.74x | 0.92% | 51.2B | |
| 27.56x | 7.53x | 23.83x | 0.05% | 51.19B | |
| 34.01x | 3.32x | 14.33x | -.--% | 43.93B | |
| 48.9x | 5.59x | 30.73x | -.--% | 41.96B | |
| -18.47x | 189.62x | -19.51x | -.--% | 38.14B | |
| 28.97x | 8.21x | 21.25x | 0.37% | 33.24B | |
| 29.19x | 6.17x | 16.01x | -.--% | 25.2B | |
| 30.74x | 5.69x | 19.09x | -.--% | 22.5B | |
| Average | 18.85x | 24.68x | 32.65x | 0.29% | 38.4B | |
| Weighted average by Cap. | 23.77x | 24.48x | 20.75x | 0.43% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- TEM Stock
- Valuation Tempus AI, Inc.
Select your edition
All financial news and data tailored to specific country editions
